Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary W Moore

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
ADAMTS13 Antibody and Inhibitor AssaysGary W Moore, Helga Vetr, Nikolaus B Binder
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 16, 2003
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulantsGary W Moore, Mark P Smith, Geoffrey F Savidge
Thrombosis Research|December 4, 2014
Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratioGary W Moore, Naomi de Jager, Jacqueline A Cutler
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
ADAMTS13 Activity Measurement by ELISA and Fluorescence Resonance Energy Transfer AssayGary W Moore, Marcos Llusa, Margaret Griffiths, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2022
Direct oral anticoagulants-Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitorsDanielle White, Gary W Moore, Martin Besser, et al.
International Journal of Laboratory Hematology|September 25, 2018
Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVTOsamu Kumano, Jean Amiral, Claire Dunois, et al.
International Journal of Laboratory Hematology|May 11, 2021
Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitorsOsamu Kumano, Jean Amiral, Claire Dunois, et al.
International Journal of Molecular Sciences|January 27, 2021
Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase ActivityMartina Leitner, Christian Büchold, Ralf Pasternack, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation CommitteeGary W Moore, Elisabetta Castoldi, Jun Teruya, et al.
British Journal of Haematology|February 9, 2012
Guidelines on the investigation and management of antiphospholipid syndromeDavid Keeling, Ian Mackie, Gary W Moore, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
ADAMTS13 Antibody and Inhibitor AssaysGary W Moore, Helga Vetr, Nikolaus B Binder
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 16, 2003
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulantsGary W Moore, Mark P Smith, Geoffrey F Savidge
Thrombosis Research|December 4, 2014
Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratioGary W Moore, Naomi de Jager, Jacqueline A Cutler
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
ADAMTS13 Activity Measurement by ELISA and Fluorescence Resonance Energy Transfer AssayGary W Moore, Marcos Llusa, Margaret Griffiths, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2022
Direct oral anticoagulants-Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitorsDanielle White, Gary W Moore, Martin Besser, et al.
International Journal of Laboratory Hematology|September 25, 2018
Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVTOsamu Kumano, Jean Amiral, Claire Dunois, et al.
International Journal of Laboratory Hematology|May 11, 2021
Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitorsOsamu Kumano, Jean Amiral, Claire Dunois, et al.
International Journal of Molecular Sciences|January 27, 2021
Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase ActivityMartina Leitner, Christian Büchold, Ralf Pasternack, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation CommitteeGary W Moore, Elisabetta Castoldi, Jun Teruya, et al.
British Journal of Haematology|February 9, 2012
Guidelines on the investigation and management of antiphospholipid syndromeDavid Keeling, Ian Mackie, Gary W Moore, et al.
Pageof 7